Inegy 10mg/80mg tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

inegy 10mg/80mg tablets

organon pharma (uk) ltd - simvastatin; ezetimibe - oral tablet - 80mg ; 10mg

Inegy 10mg/20mg tablets イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

inegy 10mg/20mg tablets

mawdsley-brooks & company ltd - simvastatin; ezetimibe - oral tablet - 20mg ; 10mg

INEGY 10/10 TABLET 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

inegy 10/10 tablet

organon south africa (pty) ltd - tablet - see ingredients - each tablet contains ezetimibe 10,0 mg simvastatin 10,0 mg

INEGY 10/20 TABLET 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

inegy 10/20 tablet

organon south africa (pty) ltd - tablet - see ingredients - each tablet contains ezetimibe 10,0 mg simvastatin 20,0 mg

INEGY 10/40 TABLET 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

inegy 10/40 tablet

organon south africa (pty) ltd - tablet - see ingredients - each tablet contains ezetimibe 10,0 mg simvastatin 40,0 mg

INEGY 10/80 TABLET 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

inegy 10/80 tablet

organon south africa (pty) ltd - tablet - see ingredients - each tablet contains ezetimibe 10,0 mg simvastatin 80,0 mg

Inegy 10 mg - 20 mg tabl. ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inegy 10 mg - 20 mg tabl.

organon n.v. - simvastatin 20 mg; ezetimibe 10 mg - tablet - simvastatin and ezetimibe

INEGY 10/20 Milligram Tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

inegy 10/20 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/20 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents

INEGY 10/80 Milligram Tablets アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

inegy 10/80 milligram tablets

merck sharp and dohme limited - ezetimibe, simvastatin - tablets - 10/80 milligram - hmg coa reductase inhibitors in combination with other lipid modifying agents